Sage Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Sage Therapeutics, Inc. has filed 818 SEC EDGAR filings since 21 Jan 2014

SEC filing history

Showing 651-675 of 818 matching filings.

Per page
25
Current page
27
4

PRIMARY DOCUMENT

Filing date
24 Jun 2016
Reporting date
22 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jun 2016
Reporting date
22 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36544

8-K

Filing date
23 Jun 2016
Reporting date
22 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36544

FORM 8-K

Filing date
31 May 2016
Reporting date
24 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2016
Reporting date
16 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2016
Reporting date
16 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36544

8-K

Filing date
03 May 2016
Reporting date
27 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36544

DEFA14A

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36544

DEF 14A

Filing date
29 Apr 2016
Reporting date
22 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Apr 2016
Reporting date
19 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Apr 2016
Reporting date
23 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36544

FORM 8-K

Filing date
16 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-209831

S-8

Filing date
29 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36544

8-K

Filing date
24 Feb 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88275

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88275

SAGE THERAPEUTICS, INC.-AMEND. #1

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88275

SC 13G/A

Filing date
10 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88275

SC 13G

Filing date
10 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .